DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Invests $10.92 Million in Encompass Health Co. (NYSE:EHC)

DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main purchased a new stake in shares of Encompass Health Co. (NYSE:EHC) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 118,207 shares of the company’s stock, valued at approximately $10,916,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main owned 0.12% of Encompass Health at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the stock. MassMutual Private Wealth & Trust FSB raised its position in shares of Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after acquiring an additional 137 shares in the last quarter. Colonial Trust Co SC bought a new position in Encompass Health in the fourth quarter worth $29,000. Transce3nd LLC purchased a new position in Encompass Health during the fourth quarter valued at $40,000. CBIZ Investment Advisory Services LLC boosted its holdings in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after buying an additional 127 shares in the last quarter. Finally, Tompkins Financial Corp purchased a new stake in shares of Encompass Health in the 4th quarter worth about $46,000. 97.25% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently commented on EHC. StockNews.com lowered shares of Encompass Health from a “buy” rating to a “hold” rating in a research note on Saturday, May 3rd. UBS Group raised their price objective on Encompass Health from $117.00 to $130.00 and gave the company a “buy” rating in a research report on Monday, April 28th. KeyCorp boosted their target price on Encompass Health from $120.00 to $122.00 and gave the stock an “overweight” rating in a report on Friday, April 25th. Truist Financial reaffirmed a “buy” rating and issued a $135.00 price target (up previously from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. Finally, Royal Bank of Canada increased their price objective on shares of Encompass Health from $110.00 to $125.00 and gave the company an “outperform” rating in a research report on Monday, April 28th. One investment analyst has rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $120.86.

Encompass Health Price Performance

Shares of NYSE:EHC opened at $116.45 on Friday. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The firm has a market cap of $11.74 billion, a price-to-earnings ratio of 26.11, a price-to-earnings-growth ratio of 2.31 and a beta of 0.91. The business has a 50-day simple moving average of $103.44 and a two-hundred day simple moving average of $99.93. Encompass Health Co. has a fifty-two week low of $82.74 and a fifty-two week high of $118.27.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.18. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The firm had revenue of $1.46 billion during the quarter, compared to analysts’ expectations of $1.43 billion. During the same period in the previous year, the company earned $1.12 earnings per share. The firm’s quarterly revenue was up 10.6% on a year-over-year basis. On average, analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.58%. The ex-dividend date is Tuesday, July 1st. Encompass Health’s dividend payout ratio (DPR) is presently 14.05%.

Insider Buying and Selling at Encompass Health

In other news, insider Elissa Joy Charbonneau sold 4,279 shares of Encompass Health stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total transaction of $498,974.19. Following the transaction, the insider now owns 11,958 shares in the company, valued at $1,394,422.38. This trade represents a 26.35 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP John Patrick Darby sold 10,000 shares of the company’s stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total value of $1,147,900.00. Following the completion of the sale, the executive vice president now owns 79,710 shares of the company’s stock, valued at $9,149,910.90. This trade represents a 11.15 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 19,321 shares of company stock valued at $2,142,452. 2.00% of the stock is owned by company insiders.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.